Style | Citing Format |
---|---|
MLA | Barzegarfallah A, et al.. "Corrigendum to “Tropisetron Attenuates High-Glucose-Induced Vascular Endothelial Dysfunction Via Inhibition of Calcineurin/Nfat Signalling” [Europ. J. Pharmacol. 994 (2025) 177389] (European Journal of Pharmacology (2025) 994, (S0014299925001438), (10.1016/J.Ejphar.2025.177389))." European Journal of Pharmacology, vol. 995, no. , 2025, pp. -. |
APA | Barzegarfallah A, Ghaffaribohlouli P, Nadjafi S, Razmi A, Dehpour AR, Ghaffarianbahraman A, Alimoradi H, Shafiei M (2025). Corrigendum to “Tropisetron Attenuates High-Glucose-Induced Vascular Endothelial Dysfunction Via Inhibition of Calcineurin/Nfat Signalling” [Europ. J. Pharmacol. 994 (2025) 177389] (European Journal of Pharmacology (2025) 994, (S0014299925001438), (10.1016/J.Ejphar.2025.177389)). European Journal of Pharmacology, 995(), -. |
Chicago | Barzegarfallah A, Ghaffaribohlouli P, Nadjafi S, Razmi A, Dehpour AR, Ghaffarianbahraman A, Alimoradi H, Shafiei M. "Corrigendum to “Tropisetron Attenuates High-Glucose-Induced Vascular Endothelial Dysfunction Via Inhibition of Calcineurin/Nfat Signalling” [Europ. J. Pharmacol. 994 (2025) 177389] (European Journal of Pharmacology (2025) 994, (S0014299925001438), (10.1016/J.Ejphar.2025.177389))." European Journal of Pharmacology 995, no. (2025): -. |
Harvard | Barzegarfallah A et al. (2025) 'Corrigendum to “Tropisetron Attenuates High-Glucose-Induced Vascular Endothelial Dysfunction Via Inhibition of Calcineurin/Nfat Signalling” [Europ. J. Pharmacol. 994 (2025) 177389] (European Journal of Pharmacology (2025) 994, (S0014299925001438), (10.1016/J.Ejphar.2025.177389))', European Journal of Pharmacology, 995(), pp. -. |
Vancouver | Barzegarfallah A, Ghaffaribohlouli P, Nadjafi S, Razmi A, Dehpour AR, Ghaffarianbahraman A, et al.. Corrigendum to “Tropisetron Attenuates High-Glucose-Induced Vascular Endothelial Dysfunction Via Inhibition of Calcineurin/Nfat Signalling” [Europ. J. Pharmacol. 994 (2025) 177389] (European Journal of Pharmacology (2025) 994, (S0014299925001438), (10.1016/J.Ejphar.2025.177389)). European Journal of Pharmacology. 2025;995():-. |
BibTex | @article{ author = {Barzegarfallah A and Ghaffaribohlouli P and Nadjafi S and Razmi A and Dehpour AR and Ghaffarianbahraman A and Alimoradi H and Shafiei M}, title = {Corrigendum to “Tropisetron Attenuates High-Glucose-Induced Vascular Endothelial Dysfunction Via Inhibition of Calcineurin/Nfat Signalling” [Europ. J. Pharmacol. 994 (2025) 177389] (European Journal of Pharmacology (2025) 994, (S0014299925001438), (10.1016/J.Ejphar.2025.177389))}, journal = {European Journal of Pharmacology}, volume = {995}, number = {}, pages = {-}, year = {2025} } |
RIS | TY - JOUR AU - Barzegarfallah A AU - Ghaffaribohlouli P AU - Nadjafi S AU - Razmi A AU - Dehpour AR AU - Ghaffarianbahraman A AU - Alimoradi H AU - Shafiei M TI - Corrigendum to “Tropisetron Attenuates High-Glucose-Induced Vascular Endothelial Dysfunction Via Inhibition of Calcineurin/Nfat Signalling” [Europ. J. Pharmacol. 994 (2025) 177389] (European Journal of Pharmacology (2025) 994, (S0014299925001438), (10.1016/J.Ejphar.2025.177389)) JO - European Journal of Pharmacology VL - 995 IS - SP - EP - PY - 2025 ER - |